Phase IV, Randomized, Open-Label Trial Comparing Long-Term Subcutaneous Low-Molecular Weight Heparin [tinzaparin sodium] With Oral Anticoagulant Therapy [acenocoumarol] in the Treatment of Deep Venous Thrombosis

Trial Profile

Phase IV, Randomized, Open-Label Trial Comparing Long-Term Subcutaneous Low-Molecular Weight Heparin [tinzaparin sodium] With Oral Anticoagulant Therapy [acenocoumarol] in the Treatment of Deep Venous Thrombosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2009

At a glance

  • Drugs Acenocoumarol; Tinzaparin sodium
  • Indications Deep vein thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top